Home > Boards > US Listed > Medical - Drugs > Albireo (ALBO)

They have a couple phase 2 drugs and

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Inspector Clouseau Member Profile
 
Followed By 24
Posts 1,011
Boards Moderated 0
Alias Born 05/10/10
160x600 placeholder
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/8/2019 9:21:17 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/8/2019 8:31:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/8/2019 8:08:44 AM
Albireo Reports Second Quarter 2019 Financial Results GlobeNewswire Inc. - 8/8/2019 7:30:00 AM
Albireo to Present at Wedbush PacGrow Healthcare Conference GlobeNewswire Inc. - 8/6/2019 8:30:00 AM
Albireo to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast GlobeNewswire Inc. - 8/1/2019 8:30:00 AM
Albireo Provides Mid-Year Clinical Development Update GlobeNewswire Inc. - 7/9/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:22:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:01:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:57:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:54:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:50:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 4:49:07 PM
Albireo Announces Launch of “PFIC Voices” GlobeNewswire Inc. - 6/20/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/18/2019 4:02:18 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/7/2019 1:38:51 PM
Data on Albireo’s Odevixibat Presented at 2019 European Society for Paediatric Gastroenterology, Hepatology and Nutrition (... GlobeNewswire Inc. - 6/7/2019 7:00:00 AM
Albireo to Present at Investor Conferences in June GlobeNewswire Inc. - 5/29/2019 7:30:00 AM
Albireo Announces Data on Pediatric Cholestatic Liver Diseases to be Presented at the 2019 ESPGHAN Annual Meeting GlobeNewswire Inc. - 5/23/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 10:10:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 7:48:30 AM
Albireo Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/9/2019 7:30:00 AM
Albireo to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast  GlobeNewswire Inc. - 5/2/2019 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 5/1/2019 4:03:38 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/1/2019 6:01:52 AM
Inspector Clouseau   Thursday, 11/03/16 05:04:00 PM
Re: Billthegoat post# 2060
Post # of 2110 
They have a couple phase 2 drugs and one phase 3 drug.They have money and can raise money with forward splits which we can benefit from,with such a tiny share structure there are many ways to benefit.Its the Nasdaq so its not like penny stocks.I think this is a winner.I think we might be the only ones here.I guess there's a couple more people here,this may be flying under the radar.Maybe we're in on the ground floor.GLTU.Go ALBO

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist